Cover Story
Conversation with The Cancer Letter
On Dec. 3, the faculty and staff members at the OHSU Knight Cancer Institute received an email from Brian J. Druker, the institution’s star scientist, former director, and current CEO, informing them that he would be stepping down from his executive role.
In Brief
Clinical Roundup
Drugs & Targets
NCI Trials
NCI Trials for December 2024
The National Cancer Institute approved the following clinical research studies last month.
